We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SARASOTA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, announced today that its Board of Directors has...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Health Canada has granted Interim Order authorization for the Lumos CoviDx™...
Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care Test Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic...
Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that Jerome Adams, MD, MPH, will serve as a Strategic Healthcare Adviser to Lumos and...
HIGHLIGHTS Annual revenues of A$25.0 million, up 198% from FY20 Commercial Services business unit delivered $22.7 million in revenues, up 188% from FY20 Products business unit generated revenue...
Global, innovative rapid point-of-care diagnostic company plans expansion and commercialization of suite of diagnostic products following ASX IPO Rapid, point-of-care (POC) diagnostics company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.001 | -2.63157894737 | 0.038 | 0.038 | 0.035 | 650674 | 0.03726823 | DE |
4 | -0.003 | -7.5 | 0.04 | 0.042 | 0.034 | 1430083 | 0.03786456 | DE |
12 | -0.009 | -19.5652173913 | 0.046 | 0.049 | 0.028 | 2213296 | 0.03677609 | DE |
26 | -0.002 | -5.12820512821 | 0.039 | 0.054 | 0.028 | 2659890 | 0.03839966 | DE |
52 | -0.053 | -58.8888888889 | 0.09 | 0.1075 | 0.028 | 3629860 | 0.05997872 | DE |
156 | -1.033 | -96.5420560748 | 1.07 | 1.265 | 0.01 | 4207836 | 0.08280252 | DE |
260 | -1.463 | -97.5333333333 | 1.5 | 1.5 | 0.01 | 3622362 | 0.09425606 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions